This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.

Released: July 12, 2026·Last reviewed: October 15, 2026·Prices re-read October 15, 2026 (rows marked)·Methodology v4.1

Researched By

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · research · corrections.

NexLife vs MEDVi: pricing, doses and services compared

Which is better for whom?

NexLife and MEDVi serve different priorities. NexLife: compounded tirzepatide $169 month to month or $139 on a 12-month plan, same price at… MEDVi: Compounded and brand-name options across 49 states. On October 15, 2026 its main page showed unfilled price… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Prices marked October 15, 2026 were re-read that day; other fields are from the July 12, 2026 review.

How do they compare, field by field?

NexLife vs MEDVi — side by side; July 12, 2026 figures, with October 15, 2026 re-reads marked
Factor	NexLife	MEDVi
Starting price	$139/mo (tirzepatide, 12-month plan) Verified	Not used: its pages print conflicting prices (Oct 15) Promotional
Renewal price	$169 month to month; $159 / $149 / $139 on 3-, 6-, 12-month plans Verified	Not printed consistently on Oct 15 Promotional
Highest-dose price	Flat — no dose-based increase Verified	Not stated on Oct 15 Promotional
Membership	$0 Verified	$0 Reported — pending verification
Labs	Not stated as included Verified	Pending research Reported — pending verification
Shipping	Included (expedited) Verified	Included Reported — pending verification
Commitment	12-month or month-to-month Verified	Monthly Reported — pending verification
Pharmacy	Plan pages name three 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA) (licences not yet independently verified by us) Verified	Not independently verified Reported — pending verification
Clinician	Medical Director: Adam Kennah, M.D. (named on NexLife’s pages; NPI provider-supplied) Verified	Physician included Reported — pending verification
States	All 50 states where its affiliated providers are licensed Verified	49 states Reported — pending verification

Which one wins on each decision factor?

Each factor below is measured from the providers’ own pages read on October 15, 2026, and the numbers are shown so you can check them. Where one program wins every factor, it is because the other printed a higher price or no price at all; the limitations sections above still apply.

Winner by decision factor, from prices and pages read October 15, 2026
Decision factor	Better fit
Lower standing monthly price (lowest plan, Oct 15)	NexLife (only one with a price on file)
Lower month-to-month price (Oct 15)	NexLife (only one with a price on file)
Names its dispensing pharmacy on its pages	NexLife
States the same price at every dose	NexLife

NexLife: who it fits

NexLife sells compounded tirzepatide for $169 a month month to month, or $159, $149 and $139 a month on 3-, 6- and 12-month plans, at the same price for every dose and with no membership fee; compounded semaglutide is $139 to $119 a month on the same terms (nexlife.us, read October 15, 2026). Its plan pages list provider review, a nutrition plan, a 1:1 wellness-coach call, 24/7 support and free expedited shipping, and name three 503A pharmacies; lab work is not stated as included. Limitation: Eden publishes a lower month-to-month price ($129 tirzepatide, $99 semaglutide, no membership). NexLife offers no brand-name pathway and no insurance coordination, and its 12-month price requires a 12-month plan. Full NexLife review →

MEDVi: who it fits

Compounded and brand-name options across 49 states. Refill rates are $299 for semaglutide and $399 for tirzepatide. Limitation: The $179 headline is a FIRST-MONTH rate only — refills are $299. Tirzepatide reaches $499/month at the 10, 12.5 and 15mg doses. Full MEDVi review →

Frequently asked questions

Is NexLife or MEDVi cheaper?

On starting price: NexLife is $139/mo (tirzepatide, 12-month plan) and MEDVi is Not used: its pages print conflicting prices (Oct 15). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.

How were these figures verified?

Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.

Sources

Both providers' pricing and terms pages, captured July 12, 2026.
Our price-normalization methodology.
CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.

Spotted an error? Submit a correction.

How the dates on this page work. Manufacturer self-pay prices were re-read on 15 October 2026: NovoCare’s Wegovy page and Lilly’s Zepbound savings page. Foundayo prices are carried from LillyDirect pages archived 25 September 2026, because lilly.com blocked automated reads. Figures captured from telehealth provider websites carry the date we read that provider’s page, which may be earlier; where it is, the row or a dated notice says so. We do not restamp a figure we have not re-read.